In October 2025, the U.S. Food and Drug Administration (FDA) granted approval to multiple new cancer therapies and supportive care options, covering treatments for acute myeloid leukemia (AML), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback